Home Cart 0 Sign in  
X

[ CAS No. 886762-71-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 886762-71-6
Chemical Structure| 886762-71-6
Chemical Structure| 886762-71-6
Structure of 886762-71-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 886762-71-6 ]

Related Doc. of [ 886762-71-6 ]

Alternatived Products of [ 886762-71-6 ]

Product Details of [ 886762-71-6 ]

CAS No. :886762-71-6 MDL No. :MFCD07368790
Formula : C6H3FINO2 Boiling Point : -
Linear Structure Formula :- InChI Key :SKOBGJNQMJCUOF-UHFFFAOYSA-N
M.W : 267.00 Pubchem ID :2783155
Synonyms :

Calculated chemistry of [ 886762-71-6 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.94
TPSA : 45.82 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.15 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.45
Log Po/w (XLOGP3) : 2.5
Log Po/w (WLOGP) : 2.76
Log Po/w (MLOGP) : 3.04
Log Po/w (SILICOS-IT) : 1.09
Consensus Log Po/w : 2.17

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.41
Solubility : 0.104 mg/ml ; 0.000391 mol/l
Class : Soluble
Log S (Ali) : -3.11
Solubility : 0.208 mg/ml ; 0.00078 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.01
Solubility : 0.262 mg/ml ; 0.000982 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.24

Safety of [ 886762-71-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H312-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 886762-71-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 886762-71-6 ]

[ 886762-71-6 ] Synthesis Path-Downstream   1~63

  • 1
  • [ 886762-71-6 ]
  • [ 74-89-5 ]
  • [ 1263413-38-2 ]
YieldReaction ConditionsOperation in experiment
In methanol; at 20℃; 1-Fluoro-3-iodo-2-nitrobenzene (2.67 g, 10 mmol; Apollo) and methylamine (2.87 g, 27% w/w solution in MeOH) were dissolved in MeOH (50 ml.) and stirred at RT overnight. The mixture was concentrated to afford the title compound (2.22 g) as a red solid.
  • 2
  • [ 886762-71-6 ]
  • [ 1263413-39-3 ]
  • 3
  • [ 886762-71-6 ]
  • [ 1263413-40-6 ]
  • 4
  • [ 886762-71-6 ]
  • [ 1263413-41-7 ]
  • 12
  • [ 886762-71-6 ]
  • 5-hydroxy-2-(4-hydroxybenzoyl)-3-(4-hydroxyphenethyl)-1,4-bis(4-hydroxyphenyl)-3,6-dihydropyrrolo[2,3,-c]carbazol-7-yl 2,2,2-trichloroethyl sulfate [ No CAS ]
  • 13
  • [ 886762-71-6 ]
  • 2-(3-(tert-butoxy)-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane [ No CAS ]
  • 14
  • [ 886762-71-6 ]
  • (4-(3-(tert-butoxy)-2-nitrophenyl)-1-(4-methoxyphenethyl)-3,7-bis(4-methoxyphenyl)-1H-indol-2-yl)(4-methoxyphenyl)methanone [ No CAS ]
  • 15
  • [ 886762-71-6 ]
  • (4-(3-(tert-butoxy)-2-nitrophenyl)-6-methoxy-1-(4-methoxyphenethyl)-3,7-bis(4-methoxyphenyl)-1H-indol-2-yl)(4-methoxyphenyl)methanone [ No CAS ]
  • 16
  • [ 886762-71-6 ]
  • [ 865-48-5 ]
  • 1-(tert-butoxy)-3-iodo-2-nitrobenzene [ No CAS ]
  • 17
  • [ 886762-71-6 ]
  • 2-ethoxy-6-iodoaniline [ No CAS ]
  • 18
  • [ 64-17-5 ]
  • [ 886762-71-6 ]
  • 1-ethoxy-3-iodo-2-nitrobenzene [ No CAS ]
YieldReaction ConditionsOperation in experiment
247 mg With potassium tert-butylate; In toluene; at 20℃; for 2h; Potassium tert-butoxide (92 mg, 0.824 mmol) was added portionwise over 5 mm to a solution of <strong>[886762-71-6]1-fluoro-3-iodo-2-nitrobenzene</strong> (200 mg, 0.749 mmol) and EtOH (0.052 mL, 0.90 mmol) intoluene (3 mL), then the mixture was stirred at RT for 2 h. FCC (toluene) afforded the title compound as a colourless solid (247 mg, assume quantitative). ?H NMR (CDC13) oe 7.41 (1H, d), 7.10 (1H, t), 7.00 (1H, d), 4.13 (2H, q), 1.40 (3H, t).
  • 19
  • [ 110-91-8 ]
  • [ 886762-71-6 ]
  • 4-(3-iodo-2-nitrophenyl)morpholine [ No CAS ]
YieldReaction ConditionsOperation in experiment
59% With potassium carbonate; In toluene; at 85℃; for 3h; To a solution of <strong>[886762-71-6]1-fluoro-3-iodo-2-nitrobenzene</strong> (228 mg, 0.854 mmol) in toluene (3 mL) was added potassium carbonate (177 mg, 1.28 mmol) and morpholine (1 mL). The mixture was heated at 85 C for 3 h. The cooled reaction mixture was evaporated and the residue partitioned between EtOAc and water. The aq. phase was extracted with more EtOAc, and the combined organic extracts were washed with water, then brine, dried (Na2SO4) and concentrated in vacuo to leave a residue. FCC (20-50% EtOAc in isohexane) gave the title compound as a light yellow solid (168 mg, 59%). M/z 335 (M+H).
  • 20
  • 3-fluoro-2-nitro-phenylamine [ No CAS ]
  • [ 886762-71-6 ]
YieldReaction ConditionsOperation in experiment
76% With tert.-butylnitrite; iodine; In acetonitrile; at 20 - 60℃; for 18h; To a pre heated solution of iodine [244.23 g, 1923.1 mmol] and tert butyl nitrite [1 14.2 ml, 961.5 mmol] in MeCN (300 mL) at 60 C, was added a solution of compound 1 [30.00 g, 192 3 mmol] in MeCN (300 mL). The reaction mixture was stirred for an additional 2 h at 60 C and allowed to stir at room temperature for another 16 h. After completion [ monitored by TLC [10% EtOAc-Hexane, Rf=0.5], the mixture was quenched with saturated aqueous Na2S2C>3 [300 mL] solution at ice cool condition and extracted with EtOAc [3x500 mL] The combined organic layers were dried (Na2S04), filtered, and concentrated under reduced pressure. The residue was purified through silica gel column chromatography using 0-3 % EtOAc-hexane as eluting solvent to afford compound 2 [39 g, 7614] as a yellow solid. [Tl NMR is consistent].
  • 21
  • [ 886762-71-6 ]
  • (S)-3-(2-amino-3-iodo-phenoxy)-2-tert-butoxycarbonylamino-propionic acid [ No CAS ]
  • 22
  • [ 886762-71-6 ]
  • ((S)-1-iodo-8-oxo-6,7,8,9-tetrahydro-5-oxa-9-aza-benzocyclohepten-7-yl)carbamic acid tert-butyl ester [ No CAS ]
  • 23
  • [ 886762-71-6 ]
  • {(S)-1-[3-(tert-butyl-dimethyl-silanyloxy)-prop-1-ynyl]-8-oxo-6,7,8,9-tetrahydro-5-oxa-9-aza-benzocyclohepten-7-yl}carbamic acid tert-butyl ester [ No CAS ]
  • 24
  • [ 886762-71-6 ]
  • [(S)-1-(tert-butyl-dimethylsilanyloxymethyl)-9-oxo-8,9-dihydro-7H-6-oxa-9a-aza-benzo[cd]azulen-8-yl]carbamic acid tert-butyl ester [ No CAS ]
  • 25
  • [ 886762-71-6 ]
  • [(S)-1-hydroxymethyl-9-oxo-8,9-dihydro-7H-6-oxa-9a-aza-benzo[cd]azulen-8-yl]carbamic acid tert-butyl ester [ No CAS ]
  • 26
  • [ 886762-71-6 ]
  • ((1S,8S)-1-hydroxymethyl-9-oxo-1,2,8,9-tetrahydro-7H-6-oxa-9a-aza-benzo[cd]azulen-8-yl)carbamic acid tert-butyl ester [ No CAS ]
  • C17H22N2O5 [ No CAS ]
  • 27
  • [ 886762-71-6 ]
  • (1S,8S)-8-tert-butoxycarbonylamino-9-oxo-1,2,8,9-tetrahydro-7H-6-oxa-9a-aza-benzo[cd]azulene-1-carboxylic acid [ No CAS ]
  • C17H20N2O6 [ No CAS ]
  • 28
  • [ 886762-71-6 ]
  • {(1S,8S)-9-oxo-1-[(1H-[1,2,3]triazol-4-ylmethyl)carbamoyl]-1,2,8,9-tetrahydro-7H-6-oxa-9a-azabenzo[cd]azulen-8-yl}-carbamic acid tert-butyl ester [ No CAS ]
  • C20H24N6O5 [ No CAS ]
  • 29
  • [ 886762-71-6 ]
  • (1S,8S)-8-amino-9-oxo-1,2,8,9-tetrahydro-7H-6-oxa-9a-aza-benzo[cd]azulene-1-carboxylic acid (1H-[1,2,3 ]triazol-4-ylmethyl)amide trifluoroacetate [ No CAS ]
  • C15H16N6O3*C2HF3O2 [ No CAS ]
  • 30
  • [ 886762-71-6 ]
  • (1S,8S)-8-((2S,3S)-2-benzoylamino-3-methyl-pentanoylamino)-9-oxo-1,2,8,9-tetrahydro-7H-6-oxa-9a-aza-benzo[cd]azulene-1-carboxylic acid (1H-[1,2,3]triazol-4-ylmethyl)amide [ No CAS ]
  • 31
  • [ 886762-71-6 ]
  • (R)-3-(2-amino-3-iodo-phenylsulfanyl)-2-tert-butoxycarbonyl-aminopropionic acid [ No CAS ]
  • 32
  • [ 886762-71-6 ]
  • ((R)-6-iodo-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl)carbamic acid tert-butyl ester [ No CAS ]
  • 33
  • [ 886762-71-6 ]
  • {(R)-6-[3-(tert-butyldimethylsilanyloxy)prop-1-ynyl]-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl}carbamic acid tert-butyl ester [ No CAS ]
  • 34
  • [ 886762-71-6 ]
  • [(R)-1-(tert-butyl-dimethyl-silanyloxymethyl)-9-oxo-8,9-dihydro-7H-6-thia-9a-aza-benzo[cd]azulen-8-yl]carbamic acid tert-butyl ester [ No CAS ]
  • 35
  • [ 886762-71-6 ]
  • [(R)-1-hydroxymethyl-9-oxo-8,9-dihydro-7H-6-thia-9a-aza-benzo[cd]azulen-8-yl]carbamic acid tert-butyl ester [ No CAS ]
  • 36
  • [ 886762-71-6 ]
  • ((8R)-1-hydroxymethyl-9-oxo-1,2, 8,9-tetrahydro-7H-6-thia-9a-aza-benzo[cd]azulen-8-yl)carbamic acid tert-butyl ester [ No CAS ]
  • 37
  • [ 886762-71-6 ]
  • (8R)-8-tert-butoxycarbonylamino-6,6,9-trioxo-1,2,6,7,8,9-hexahydro-6λ6-thia-9a-aza-benzo[cd]azulene-1-carboxylic acid [ No CAS ]
  • 38
  • [ 886762-71-6 ]
  • {(8R)-6,6,9-trioxo-1-[(1H-[1,2,3]triazol-4-ylmethyl)-carbamoyl]-1,2,6,7,8,9-hexahydro-6λ6-thia-9a-aza-benzo[cd]azulen-8-yl}carbamic acid tert-butyl ester [ No CAS ]
  • 39
  • [ 886762-71-6 ]
  • (8R)-8-amino-6,6,9-trioxo-1,2,6,7,8,9-hexahydro-6λ6-thia-9a-aza-benzo[cd]azulene-1-carboxylic acid (1H-[1,2,3]triazol-4-ylmethyl)amide trifluoroacetate [ No CAS ]
  • 40
  • [ 886762-71-6 ]
  • (1S,8R)-8-{(2S,3S)-2-[2-(2-fluoroethoxy)acetylamino]-3-methyl-pentanoylamino}-6,6,9-trioxo-1,2,6,7,8,9-hexahydro-6λ6-thia-9a-aza-benzo[cd]azulene-1-carboxylic acid (1H-[1,2,3]triazol-4-ylmethyl)amide [ No CAS ]
  • C25H32FN7O7S [ No CAS ]
  • 41
  • [ 886762-71-6 ]
  • (S)-3-(2-amino-3-iodo-phenylamino)-2-tert-butoxycarbonyl-aminopropionic acid [ No CAS ]
  • 42
  • [ 886762-71-6 ]
  • ((S)-9-iodo-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)carbamic acid tert-butyl ester [ No CAS ]
  • 43
  • [ 886762-71-6 ]
  • {(S)-9-[3-(tert-butyl-dimethylsilanyloxy)-prop-1-ynyl]-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl}carbamic acid tert-butyl ester [ No CAS ]
  • 44
  • [ 886762-71-6 ]
  • [(S)-6-(tert-butyl-dimethylsilanyloxymethyl)-4-oxo-1,2,3,4-tetrahydro-[1,4]diazepino[3,2,1-hi]indol-3-yl]carbamic acid tert-butyl ester [ No CAS ]
  • 45
  • [ 886762-71-6 ]
  • ((S)-6-hydroxymethyl-4-oxo-1,2,3,4-tetrahydro-[1,4]diazepino[3,2,1-hi]indol-3-yl)carbamic acid tert-butyl ester [ No CAS ]
  • 46
  • [ 886762-71-6 ]
  • ((3S,6S)-6-hydroxymethyl-4-oxo-1,2,3,4,6,7-hexahydro-[1,4]diazepino[3,2,1-hi]indol-3-yl)-carbamic acid tert-butyl ester [ No CAS ]
  • C17H23N3O4 [ No CAS ]
  • 47
  • [ 886762-71-6 ]
  • (3S,6S)-3-tert-butoxycarbonylamino-6-hydroxymethyl-4-oxo-3,4,6,7-tetrahydro-2H-[1,4]diazepino[3,2,1-hi]indole-1-carboxylic acid benzyl ester [ No CAS ]
  • C25H29N3O6 [ No CAS ]
  • 48
  • [ 886762-71-6 ]
  • (3S,6S)-3-tert-butoxycarbonylamino-4-oxo-3,4,6,7-tetrahydro-2H-[1,4]diazepino[3,2,1-hi]indole-1,6-dicarboxylic acid 1-benzyl ester [ No CAS ]
  • C25H27N3O7 [ No CAS ]
  • 49
  • [ 886762-71-6 ]
  • (3S,6S)-3-tert-butoxycarbonylamino-4-oxo-6-[(1H-[1,2,3]triazol-4-ylmethyl)carbamoyl]-3,4,6,7-tetrahydro-2H-[1,4]diazepino[3,2,1-hi]indole-1-carboxylic acid benzyl ester [ No CAS ]
  • C28H31N7O6 [ No CAS ]
  • 50
  • [ 886762-71-6 ]
  • (3S,6S)-3-amino-4-oxo-6-[(1H-[1,2,3]triazol-4-ylmethyl)-carbamoyl]-3,4,6,7-tetrahydro-2H-[1,4]diazepino[3,2,1-hi]indole-1-carboxylic acid benzyl ester trifluoroacetate [ No CAS ]
  • 51
  • [ 886762-71-6 ]
  • (3S,6S)-3-{(2S,3S)-2-[2-(2-fluoroethoxy)acetylamino]-3-methyl-pentanoylamino}-4-oxo-1,2,3,4,6,7-hexahydro-[1,4]diazepino[3,2,1-hi]indole-6-carboxylic acid (1H-[1,2,3]triazol-4-ylmethyl)amide [ No CAS ]
  • C25H33FN8O5 [ No CAS ]
  • 52
  • [ 886762-71-6 ]
  • [(S)-6-(tert-butyl-dimethylsilanyloxymethyl)-1-methyl-4-oxo-1,2,3,4-tetrahydro-[1,4]diazepino[3,2,1-hi]indol-3-yl]carbamic acid tert-butyl ester [ No CAS ]
  • 53
  • [ 886762-71-6 ]
  • ((S)-6-hydroxymethyl-1-methyl-4-oxo-1,2,3,4-tetrahydro-[1,4]diazepino[3,2,1-hi]indol-3-yl)carbamic acid tert-butyl ester [ No CAS ]
  • 54
  • [ 886762-71-6 ]
  • ((3S,6S)-6-hydroxymethyl-1-methyl-4-oxo-1,2,3,4,6,7-hexahydro-[1,4]diazepino[3,2,1-hi]indol-3-yl)-carbamic acid tert-butyl ester [ No CAS ]
  • C18H25N3O4 [ No CAS ]
  • 55
  • [ 886762-71-6 ]
  • (3S,6S)-3-tert-butoxycarbonylamino-1-methyl-4-oxo-1,2,3,4,6,7-hexahydro-[1,4]diazepino[3,2,1-hi]indole-6-carboxylic acid [ No CAS ]
  • C18H23N3O5 [ No CAS ]
  • 56
  • [ 886762-71-6 ]
  • {(3S,6S)-1-methyl-4-oxo-6-[(1H-[1,2,3]triazol-4-ylmethyl)carbamoyl]-1,2,3,4,6,7-hexahydro-[1,4]diazepino[3,2,1-hi]indol-3-yl}carbamic acid tert-butyl ester [ No CAS ]
  • C21H27N7O4 [ No CAS ]
  • 57
  • [ 886762-71-6 ]
  • (3S,6S)-3-amino-1-methyl-1,2,3,4,6,7-hexahydro-[1,4]diazepino[3,2,1-hi]indole-6-carboxylic acid (1H-[1,2,3]triazol-4-ylmethyl)amide trifluoroacetate [ No CAS ]
  • C16H19N7O2*C2HF3O2 [ No CAS ]
  • 58
  • [ 886762-71-6 ]
  • (3S,6S)-3-{(2S,3S)-2-[2-(2-fluoroethoxy)acetylamino]-3-methyl-pentanoylamino}-1-methyl-4-oxo-1,2,3,4,6,7-hexahydro-[1,4]diazepino[3,2,1-hi]indole-6-carboxylic acid (1H-[1,2,3]triazol-4-ylmethyl)amide [ No CAS ]
  • C26H35FN8O5 [ No CAS ]
  • 59
  • [ 886762-71-6 ]
  • [ 3262-72-4 ]
  • (S)-2-tert-butoxycarbonylamino-3-(3-iodo-2-nitro-phenoxy)propionic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
47.6% To a stirred suspension of NaH (50%) [3.60 g, 74.9 mmol] in DMF [60 mL] was added slowly a solution of compound 3 [15.3 g, 74.9 mmol] in DMF [30 mL] maintaining the external temperature below -10 C. After addition, reaction mixture was left stirring vigorously for half an hour under cold condition. A solution of compound 2 [20.0 g, 74.9 mmol] in DMF [30 mL] was slowly added to the reaction mixture under ice cold condition, after addition reaction mixture was allowed to warm at room temperature and stirred for 16 h. Then reaction mixture was quenched with water [500 mL] and aqueous part was extracted with EtOAc [2x100 mL j. Organic part was separated; pH of the aqueous part was slowly adjusted to 2-3 using IN aqueous HC1 under ice cooled condition and immediately extracted with EtOAc [2x300 ml]. Organic part was separated, dried (MgS04) and concentrated under reduced pressure to afford 7.2 g of compound 4. 15 g of un-reacted starting material was also recovered; this material was further treated under the same condition to afford 8.5 g compound 4 [total 16.1 g, 47.6 %]. Mass [ESI]: m/z 452.21 [MM]
  • 60
  • [ 886762-71-6 ]
  • [ 20887-95-0 ]
  • (R)-2-tert-butoxycarbonylamino-3-(3-iodo-2-nitro-phenylsulfanyl)propionic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
43% NaHCOs [5.70 g, 67.8 mmol] was added to a stirred solution of compound 3 [5.00 g, 22.6 mmol] in water (30 mL) at room temperature under argon atmosphere and stirred for 10 minutes. Finally, solution of compound 2 [4.22 g, 15.8 mmol] in EtOH (40 mL) was added to the reaction mixture and stirred at 80 C for 4 h. After completion, solvent was evaporated, crude was diluted with water [200 mL] and extracted with Et?.0 [200 mLj. Organic part was separated; pH of the aqueous part was slowly adjusted to 2-3 using 1 (N) aqueous HC1 under ice cooled condition and immediately extracted with EtOAc [2x100 mi]. Organic part was separated, dried [Na2SQ4] and concentrated under reduced pressure to afford compound 4 [4.5 g, 43%]. Mass [ESI]: m/z 468.27 [M++l ]
  • 61
  • [ 886762-71-6 ]
  • [ 76387-70-7 ]
  • (S)-2-tert-butoxycarbonylamino-3-(3-iodo-2-nitro-phenylamino)propionic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
68.4% K2CO3 [5.20 g, 37.7mmoi] was added to a stirred suspension of compound 3 [7.0 g, 34 mmol] in EtOH (230 mL) under ice cold condition. After addition reaction mixture was left to stir vigorously for half an hour under cold condition. Finally, compound 2 [9.16 g, 34.3 mmol] was added portion wise to the reaction mixture at 0 C, after addition reaction mixture was brought to room temperature and heated at 80 C for 40 h. After completion, EtOH were evaporated, crude was diluted with water [200 mL] and extracted with EI2O [200 L] Organic part was separated; pH of the aqueous part was slowly adjusted to 2-3 using 1 (N) aqueous HC1 under ice cooled condition and immediately extracted with EtOAc [2x200 mL] Organic part was separated, dried [MgSOr] and concentrated under reduced pressure to afford compound 4 [10.6 g, 68 4 %] as dark red floppy solid. Mass [ESI]: ra/z 451.21 j .1 - l 1.
  • 62
  • [ 16433-96-8 ]
  • [ 886762-71-6 ]
  • 1-fluoro-2-nitro-3-((2-nitrophenyl)ethynyl)benzene [ No CAS ]
  • 63
  • [ 5378-27-8 ]
  • [ 886762-71-6 ]
  • 2-[4-(3-iodo-2-nitrophenoxy)phenyl]-1,3,4-oxadiazole [ No CAS ]
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 886762-71-6 ]

Fluorinated Building Blocks

Chemical Structure| 771-05-1

[ 771-05-1 ]

1,5-Difluoro-3-iodo-2-nitrobenzene

Similarity: 0.97

Chemical Structure| 3819-88-3

[ 3819-88-3 ]

1-Fluoro-3-iodo-5-nitrobenzene

Similarity: 0.84

Chemical Structure| 2996-31-8

[ 2996-31-8 ]

2-Fluoro-4-iodo-1-nitrobenzene

Similarity: 0.81

Chemical Structure| 41860-64-4

[ 41860-64-4 ]

4-Fluoro-2-iodo-1-nitrobenzene

Similarity: 0.80

Chemical Structure| 177363-10-9

[ 177363-10-9 ]

1-Fluoro-2-iodo-4-nitrobenzene

Similarity: 0.80

Aryls

Chemical Structure| 771-05-1

[ 771-05-1 ]

1,5-Difluoro-3-iodo-2-nitrobenzene

Similarity: 0.97

Chemical Structure| 3819-88-3

[ 3819-88-3 ]

1-Fluoro-3-iodo-5-nitrobenzene

Similarity: 0.84

Chemical Structure| 2996-31-8

[ 2996-31-8 ]

2-Fluoro-4-iodo-1-nitrobenzene

Similarity: 0.81

Chemical Structure| 41860-64-4

[ 41860-64-4 ]

4-Fluoro-2-iodo-1-nitrobenzene

Similarity: 0.80

Chemical Structure| 177363-10-9

[ 177363-10-9 ]

1-Fluoro-2-iodo-4-nitrobenzene

Similarity: 0.80

Nitroes

Chemical Structure| 771-05-1

[ 771-05-1 ]

1,5-Difluoro-3-iodo-2-nitrobenzene

Similarity: 0.97

Chemical Structure| 3819-88-3

[ 3819-88-3 ]

1-Fluoro-3-iodo-5-nitrobenzene

Similarity: 0.84

Chemical Structure| 2996-31-8

[ 2996-31-8 ]

2-Fluoro-4-iodo-1-nitrobenzene

Similarity: 0.81

Chemical Structure| 41860-64-4

[ 41860-64-4 ]

4-Fluoro-2-iodo-1-nitrobenzene

Similarity: 0.80

Chemical Structure| 177363-10-9

[ 177363-10-9 ]

1-Fluoro-2-iodo-4-nitrobenzene

Similarity: 0.80